Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform

BACKGROUND: The detection of somatic mutations in primary tumors is critical for the understanding of cancer evolution and targeting therapy. Multiple technologies have been developed to enable the detection of such mutations. Next generation sequencing (NGS) is a new platform that is gradually beco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Darwanto, Agus, Hein, Anne-Mette, Strauss, Sascha, Kong, Yi, Sheridan, Andrew, Richards, Dan, Lader, Eric, Ngowe, Monika, Pelletier, Timothy, Adams, Danielle, Ricker, Austin, Patel, Nishit, Kühne, Andreas, Hughes, Simon, Shiffman, Dan, Zimmermann, Dirk, te Kaat, Kai, Rothmann, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441096/
https://ncbi.nlm.nih.gov/pubmed/28532404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3328-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados